CatS inhibition with selective inhibitor RO5459072 was able to block Lip10 degradation in healthy donor- and systemic lupus erythematosus (SLE) patient-derived B cells and supress the induction of proinflammatory macrophages ex vivo. This evidence concerns the gene PIMREG and systemic lupus erythematosus.